Tazarotene is indicated for the topical treatment of mild to moderate plaque psoriasis involving up to 10% body surface area.
For this indication, competent medicine agencies globally authorize below treatments:
Cutaneous
1 - 1 {spreads}
From 1 To 1 {spreads} once every day
A thin film of the gel should be applied once daily in the evening; care should be taken to apply it only to areas of affected skin, avoiding application to healthy skin or in skin folds. Treatment is limited to 10% body surface area (approximately equivalent to the total skin area of one arm).
If the patient experiences more drying or irritation, an effective greasy emollient (without pharmaceutically active ingredients) can be applied to the areas of the skin to be treated to improve tolerability. Healthy skin around the psoriatic plaques can be covered by using zinc paste, for example, to prevent irritation.
Usually, the treatment period is up to 12 weeks. Clinical experience, particularly on tolerability, is available on periods of use of up to 12 months.